The gut microbiota, bacterial metabolites and colorectal cancer

Petra Louis, Georgina L. Hold, Harry J. Flint (Corresponding Author)

Research output: Contribution to journalLiterature review

633 Citations (Scopus)

Abstract

Accumulating evidence suggests that the human intestinal microbiota contributes to the aetiology of colorectal cancer (CRC), not only via the pro-carcinogenic activities of specific pathogens but also via the influence of the wider microbial community, particularly its metabolome. Recent data have shown that the short-chain fatty acids acetate, propionate and butyrate function in the suppression of inflammation and cancer, whereas other microbial metabolites, such as secondary bile acids, promote carcinogenesis. In this Review, we discuss the relationship between diet, microbial metabolism and CRC and argue that the cumulative effects of microbial metabolites should be considered in order to better predict and prevent cancer progression.
Original languageEnglish
Pages (from-to)661-672
Number of pages12
JournalNature Reviews Microbiology
Volume12
Issue number10
Early online date8 Sep 2014
DOIs
Publication statusPublished - Oct 2014

Fingerprint

Colorectal Neoplasms
Metabolome
Volatile Fatty Acids
Butyrates
Propionates
Bile Acids and Salts
Neoplasms
Carcinogenesis
Acetates
Diet
Inflammation
Gastrointestinal Microbiome

Cite this

The gut microbiota, bacterial metabolites and colorectal cancer. / Louis, Petra; Hold, Georgina L.; Flint, Harry J. (Corresponding Author).

In: Nature Reviews Microbiology, Vol. 12, No. 10, 10.2014, p. 661-672.

Research output: Contribution to journalLiterature review

@article{068dab8bfa7a4b61ba1a6169c89d9408,
title = "The gut microbiota, bacterial metabolites and colorectal cancer",
abstract = "Accumulating evidence suggests that the human intestinal microbiota contributes to the aetiology of colorectal cancer (CRC), not only via the pro-carcinogenic activities of specific pathogens but also via the influence of the wider microbial community, particularly its metabolome. Recent data have shown that the short-chain fatty acids acetate, propionate and butyrate function in the suppression of inflammation and cancer, whereas other microbial metabolites, such as secondary bile acids, promote carcinogenesis. In this Review, we discuss the relationship between diet, microbial metabolism and CRC and argue that the cumulative effects of microbial metabolites should be considered in order to better predict and prevent cancer progression.",
author = "Petra Louis and Hold, {Georgina L.} and Flint, {Harry J.}",
note = "P.L. and H.F. acknowledge support from the Scottish Government Food Land and People programme. The authors thank A. Walker and R. Barker for critical reading of the manuscript.",
year = "2014",
month = "10",
doi = "10.1038/nrmicro3344",
language = "English",
volume = "12",
pages = "661--672",
journal = "Nature Reviews Microbiology",
issn = "1740-1526",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - The gut microbiota, bacterial metabolites and colorectal cancer

AU - Louis, Petra

AU - Hold, Georgina L.

AU - Flint, Harry J.

N1 - P.L. and H.F. acknowledge support from the Scottish Government Food Land and People programme. The authors thank A. Walker and R. Barker for critical reading of the manuscript.

PY - 2014/10

Y1 - 2014/10

N2 - Accumulating evidence suggests that the human intestinal microbiota contributes to the aetiology of colorectal cancer (CRC), not only via the pro-carcinogenic activities of specific pathogens but also via the influence of the wider microbial community, particularly its metabolome. Recent data have shown that the short-chain fatty acids acetate, propionate and butyrate function in the suppression of inflammation and cancer, whereas other microbial metabolites, such as secondary bile acids, promote carcinogenesis. In this Review, we discuss the relationship between diet, microbial metabolism and CRC and argue that the cumulative effects of microbial metabolites should be considered in order to better predict and prevent cancer progression.

AB - Accumulating evidence suggests that the human intestinal microbiota contributes to the aetiology of colorectal cancer (CRC), not only via the pro-carcinogenic activities of specific pathogens but also via the influence of the wider microbial community, particularly its metabolome. Recent data have shown that the short-chain fatty acids acetate, propionate and butyrate function in the suppression of inflammation and cancer, whereas other microbial metabolites, such as secondary bile acids, promote carcinogenesis. In this Review, we discuss the relationship between diet, microbial metabolism and CRC and argue that the cumulative effects of microbial metabolites should be considered in order to better predict and prevent cancer progression.

U2 - 10.1038/nrmicro3344

DO - 10.1038/nrmicro3344

M3 - Literature review

VL - 12

SP - 661

EP - 672

JO - Nature Reviews Microbiology

JF - Nature Reviews Microbiology

SN - 1740-1526

IS - 10

ER -